The enhancing effect of donor pretreatment and low dose immunosuppression in dogs.
D000818:Animals; D001379:Azathioprine / Q000009:adverse effects / Q000494:pharmacology; D003404:Creatinine / Q000097:blood; D003520:Cyclophosphamide / Q000494:pharmacology / Q000627:therapeutic use*; D004285:Dogs; D006085:Graft Survival / Q000187:drug effects; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D008297:Male; D008775:Methylprednisolone / Q000494:pharmacology / Q000627:therapeutic use*; D008954:Models, Biological; D011292:Premedication; D016038:Skin Transplantation; D014019:Tissue Donors; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous
D003520:Cyclophosphamide; D003404:Creatinine; D001379:Azathioprine; D008775:Methylprednisolone